1. PAH Therapy Revisited

3. Prostacyclin Pathway in PAH

4. Case Scenario Presentation

5. Case Scenario Workup

6. Case Scenario Treatment

7. Case Scenario Right Heart Catheterization for PAH Diagnosis

8. Intravenous Epoprostenol vs Conventional Therapy in PAH

9. Therapies Targeting the Prostacyclin Pathway

10. Case Scenario

11. Transition From Inhaled to Parenteral Treprostinil Rescues PAH Patients

12. Case Scenario

13. End Points in PAH Clinical Trials

14. REVEAL Registry for PAH

15. REVEAL Registry Predictive Value of Clinical Worsening Definition

16. Prevention of Clinical Worsening

17. REVEAL Treatment at Time of Death

18. FREEDOM Trials Oral Treprostinil

19. GRIPHON Selexipag Reduces Morbidity and Mortality in PAH

21. Conclusions

22. Conclusions

23. Abbreviations

24. Abbreviations (cont)

25. References

26. References (cont)

27. References (cont)

28. References (cont)